Delivery Order SPE2DB20D2014-SPE2DB24FB55F

Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,436.44 firm fixed-price delivery order contract (SPE2DX15D3015|SPE2DX24F0EN0) to AmerisourceBergen Drug Corp for the supply of 4,563,434,205 units of Losartan-HCTZ 50-12.5 mg tablets. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $7,105.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical....
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $6,725.05 firm fixed-price contract is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a...
This is a $8,281.55 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has an ultimate completion date of July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,103.05, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of July 29, 2024. The contract is not designated as a set-aside and is an open competition award. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,320.65 firm fixed-price delivery order contract is for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of May 16, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award, valued at $1,513.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,156.16, is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of March 12, 2025 and is a Firm Fixed Price Delivery Order. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has a firm fixed price of $30,541.60 and a period of performance through July 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,895.96, is a Firm Fixed Price Delivery Order for the supply of Losartan-HCTZ 50-12.5 mg tablets. The contract has an ultimate completion date of January 17, 2025 and is not associated with any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB55F
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,988.53 firm fixed price delivery order is for the supply of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.

Generated 7/8/24, 9:34 AM